Precigen (PGEN) Financials

$1.39 +0.02 (+1.46%)

Closing price 04/17/2025 04:00 PM Eastern

Extended Trading

$1.49 +0.10 (+7.12%)

As of 04/17/2025 06:07 PM Eastern

Annual Income Statements for Precigen

This table shows Precigen's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2022	2023	2024
Net Income / (Loss) Attributable to Common Shareholders	28	-96	-126
Consolidated Net Income / (Loss)	35	-96	-126
Net Income / (Loss) Continuing Operations	-80	-96	-126
Total Pre-Tax Income	-80	-96	-128
Total Operating Income	-76	-99	-135
Total Gross Profit	21	0.11	-4.27
Total Revenue	27	6.23	0.00
Total Cost of Revenue	6.34	6.12	4.27
Operating Cost of Revenue	6.34	6.12	4.27
Total Operating Expenses	96	99	142
Selling, General & Admin Expense	48	40	41
Research & Development Expense	47	49	53
Impairment Charge	1.12	10	48
Total Other Income / (Expense), net	2.53	3.86	7.00
Interest & Investment Income	1.00	3.24	1.42
Other Income / (Expense), net	1.54	0.63	14
Income Tax Expense	-0.19	-	-3.59
Basic Earnings per Share	$0.14	($0.39)	($0.47)
Weighted Average Basic Shares Outstanding	200.36M	244.54M	267.73M
Diluted Earnings per Share	$0.14	($0.39)	($0.47)
Weighted Average Diluted Shares Outstanding	200.36M	244.54M	267.73M
Weighted Average Basic & Diluted Shares Outstanding	252.19M	248.92M	294.04M

This table shows Precigen's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Net Income / (Loss) Attributable to Common Shareholders	87	-22	-23	-20	-20	-33	-24	-58	-24	-21
Consolidated Net Income / (Loss)	87	-15	-23	-20	-20	-33	-24	-59	-24	-20
Net Income / (Loss) Continuing Operations	-7.64	-22	-23	-20	-20	-34	-24	-58	-24	-21
Total Pre-Tax Income	-7.69	-22	-23	-20	-20	-33	-24	-60	-24	-20
Total Operating Income	-7.61	-22	-23	-21	-21	-34	-24	-61	-21	-29
Total Gross Profit	15	0.51	0.32	0.07	-0.16	-0.13	-0.01	0.42	-0.06	-4.62
Total Revenue	17	1.76	1.85	1.77	1.38	1.23	1.07	1.43	0.95	-3.45
Total Cost of Revenue	1.58	1.26	1.53	1.70	1.54	1.36	1.08	1.01	1.01	1.17
Operating Cost of Revenue	1.58	1.26	1.53	1.70	1.54	1.36	1.08	1.01	1.01	1.17
Total Operating Expenses	23	22	24	21	21	34	24	62	21	34
Selling, General & Admin Expense	10	12	12	9.32	9.20	10	10	10	9.84	11
Research & Development Expense	13	11	12	12	12	13	14	16	11	12
Total Other Income / (Expense), net	-0.08	6.40	0.69	0.87	1.14	1.17	0.64	0.36	-2.70	8.70
Interest & Investment Income	0.92	0.00	0.63	0.83	0.86	0.92	0.61	0.32	0.28	0.21
Other Income / (Expense), net	1.04	0.26	0.38	0.04	0.28	-0.08	0.04	0.04	-2.99	17
Income Tax Expense	-0.05	0.01	-0.11	-0.07	-0.01	-	-0.06	-3.38	0.01	-0.16
Basic Earnings per Share	$0.44	($0.11)	($0.10)	($0.08)	($0.08)	($0.13)	($0.10)	($0.23)	($0.09)	($0.05)
Weighted Average Basic Shares Outstanding	200.67M	200.36M	229.77M	248.00M	248.52M	244.54M	249.22M	252.37M	275.88M	267.73M
Diluted Earnings per Share	$0.44	($0.11)	($0.10)	($0.08)	($0.08)	($0.13)	($0.10)	($0.23)	($0.09)	($0.05)
Weighted Average Diluted Shares Outstanding	200.67M	200.36M	229.77M	248.00M	248.52M	244.54M	249.22M	252.37M	275.88M	267.73M
Weighted Average Basic & Diluted Shares Outstanding	208.15M	252.19M	255.48M	255.48M	248.92M	248.92M	252.42M	252.76M	292.87M	294.04M

This table details how cash moves in and out of Precigen's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2022	2023	2024
Net Change in Cash & Equivalents	5.25	-41	22
Net Cash From Operating Activities	-65	-67	-68
Net Cash From Continuing Operating Activities	-65	-67	-68
Net Income / (Loss) Continuing Operations	28	-96	-126
Consolidated Net Income / (Loss)	28	-96	-126
Depreciation Expense	11	6.67	4.53
Amortization Expense	1.87	-1.75	-0.88
Non-Cash Adjustments To Reconcile Net Income	-70	7.46	52
Changes in Operating Assets and Liabilities, net	-36	17	2.73
Net Cash From Investing Activities	226	-3.09	-21
Net Cash From Continuing Investing Activities	226	-3.09	-21
Purchase of Property, Plant & Equipment	-4.92	-1.54	-8.58
Purchase of Investments	0.00	-185	-187
Sale of Property, Plant & Equipment	0.59	0.10	0.06
Divestitures	162	0.00	0.00
Sale and/or Maturity of Investments	68	183	175
Net Cash From Financing Activities	-155	30	111
Net Cash From Continuing Financing Activities	-155	30	111
Repayment of Debt	-155	-43	0.00
Issuance of Preferred Equity	0.00	0.00	79
Issuance of Common Equity	0.00	73	31
Other Financing Activities, net	0.00	0.00	0.35
Effect of Exchange Rate Changes	-0.83	-0.32	-0.03
Cash Interest Paid	8.54	1.17	0.01
Cash Income Taxes Paid	0.00	0.02	0.00

This table details how cash moves in and out of Precigen's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Net Change in Cash & Equivalents	42	-43	-25	-6.99	-6.62	-2.49	9.90	-8.14	15	4.79
Net Cash From Operating Activities	-24	-15	-18	-16	-17	-16	-14	-23	-23	-8.24
Net Cash From Continuing Operating Activities	-24	-15	-18	-16	-17	-16	-14	-23	-23	-8.24
Net Income / (Loss) Continuing Operations	87	-22	-23	-20	-20	-33	-24	-59	-24	-20
Consolidated Net Income / (Loss)	87	-22	-23	-20	-20	-33	-24	-59	-24	-20
Depreciation Expense	2.53	1.72	1.71	1.69	1.65	1.61	1.60	1.60	0.67	0.66
Amortization Expense	0.54	0.27	-0.17	-0.49	-0.57	-0.52	-0.40	-0.17	-0.16	-0.15
Non-Cash Adjustments To Reconcile Net Income	-94	16	3.57	2.20	1.61	0.09	3.08	35	5.00	8.94
Changes in Operating Assets and Liabilities, net	-20	-11	-0.77	1.16	0.10	16	5.37	-0.41	-4.27	2.04
Net Cash From Investing Activities	182	11	-50	24	11	13	24	15	5.65	-65
Net Cash From Continuing Investing Activities	182	11	-50	24	11	13	24	15	5.65	-65
Purchase of Property, Plant & Equipment	-1.57	-0.05	-0.15	-0.10	-0.24	-1.05	-4.35	-2.32	-0.88	-1.03
Purchase of Investments	-	-	-108	-20	-25	-31	-17	-34	-23	-112
Sale and/or Maturity of Investments	21	11	58	44	36	46	46	52	30	48
Net Cash From Financing Activities	-116	-39	44	-15	-	-	0.00	0.05	32	78
Net Cash From Continuing Financing Activities	-116	-39	44	-15	-	-	0.00	0.05	32	78
Issuance of Common Equity	-	-	74	-0.69	-	-	0.00	-	32	-0.60
Effect of Exchange Rate Changes	-0.33	-0.02	-0.03	-0.14	-0.13	-0.01	-0.06	-0.04	0.07	-0.00

This table presents Precigen's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2022	2023	2024
Total Assets	216	151	145
Total Current Assets	118	69	102
Cash & Equivalents	4.86	7.58	30
Short-Term Investments	51	55	68
Accounts Receivable	14	1.58	1.16
Prepaid Expenses	5.07	4.33	3.34
Plant, Property, & Equipment, net	7.33	7.11	14
Total Noncurrent Assets	90	75	29
Goodwill	37	27	19
Intangible Assets	44	41	4.46
Other Noncurrent Operating Assets	9.11	7.86	5.43
Total Liabilities & Shareholders' Equity	216	151	145
Total Liabilities	90	33	79
Total Current Liabilities	79	23	22
Accounts Payable	4.07	1.73	3.53
Accrued Expenses	5.00	6.22	4.81
Current Deferred Revenue	0.03	0.51	0.59
Current Employee Benefit Liabilities	6.38	8.25	8.42
Other Current Liabilities	20	6.28	4.17
Total Noncurrent Liabilities	11	9.56	57
Noncurrent Deferred Revenue	1.82	1.82	1.93
Noncurrent Deferred & Payable Income Tax Liabilities	2.26	1.85	0.00
Other Noncurrent Operating Liabilities	6.99	5.90	55
Commitments & Contingencies	0.00	0.00	0.00
Redeemable Noncontrolling Interest	-	0.00	28
Total Equity & Noncontrolling Interests	126	118	39
Total Preferred & Common Equity	126	118	39
Total Common Equity	126	118	39
Common Stock	1,998	2,085	2,129
Retained Earnings	-1,869	-1,964	-2,091
Accumulated Other Comprehensive Income / (Loss)	-3.49	-1.95	0.01

This table presents Precigen's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q1 2023	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024
Total Assets	259	242	208	191	135	73	83
Total Current Assets	163	138	106	93	50	24	35
Cash & Equivalents	9.07	9.74	17	10	17	9.35	25
Short-Term Investments	62	94	72	64	27	10	3.91
Accounts Receivable	2.45	16	14	14	1.16	1.02	0.73
Prepaid Expenses	6.36	4.33	2.79	5.13	3.63	3.16	5.15
Plant, Property, & Equipment, net	7.61	6.91	6.57	7.12	13	13	14
Total Noncurrent Assets	89	97	95	91	73	36	35
Goodwill	37	37	37	37	27	25	25
Intangible Assets	42	44	43	40	39	5.09	4.77
Other Noncurrent Operating Assets	9.70	8.62	8.57	7.99	7.41	5.99	5.73
Total Liabilities & Shareholders' Equity	259	242	208	191	135	73	83
Total Liabilities	117	57	41	43	38	30	28
Total Current Liabilities	105	47	31	33	29	23	21
Accounts Payable	4.20	3.81	2.51	2.35	4.72	4.85	4.32
Accrued Expenses	12	23	3.26	4.12	7.30	6.64	5.68
Current Deferred Revenue	0.08	0.02	0.02	0.51	0.41	0.38	0.41
Current Employee Benefit Liabilities	5.79	4.96	4.82	6.62	9.96	6.68	6.61
Other Current Liabilities	1.04	1.24	20	19	6.39	4.48	4.20
Total Noncurrent Liabilities	12	11	11	10	9.05	6.97	6.88
Noncurrent Deferred Revenue	1.82	1.82	1.82	1.82	1.89	1.82	2.03
Noncurrent Deferred & Payable Income Tax Liabilities	2.09	2.24	2.18	2.13	1.78	0.08	0.09
Other Noncurrent Operating Liabilities	7.94	6.62	6.55	6.19	5.39	5.07	4.76
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	143	184	166	148	97	43	55
Total Preferred & Common Equity	143	184	166	148	97	43	55
Total Common Equity	143	184	166	148	97	43	55
Common Stock	1,996	2,078	2,080	2,083	2,088	2,093	2,126
Retained Earnings	-1,846	-1,891	-1,912	-1,931	-1,988	-2,047	-2,071
Accumulated Other Comprehensive Income / (Loss)	-7.18	-2.70	-2.52	-3.56	-2.80	-2.91	0.01

This table displays calculated financial ratios and metrics derived from Precigen's official financial filings.

Metric	2022	2023	2024
Growth Metrics	-	-	-
Revenue Growth	88.61%	-76.87%	-100.00%
EBITDA Growth	6.25%	-52.35%	-25.09%
EBIT Growth	19.69%	-33.02%	-22.55%
NOPAT Growth	17.64%	-31.15%	-35.96%
Net Income Growth	138.07%	-373.30%	-31.63%
EPS Growth	129.79%	-378.57%	-20.51%
Operating Cash Flow Growth	-16.63%	-2.90%	-1.86%
Free Cash Flow Firm Growth	-451.38%	11.48%	86.00%
Invested Capital Growth	14.88%	-20.72%	-156.03%
Revenue Q/Q Growth	165.10%	-7.91%	-100.00%
EBITDA Q/Q Growth	-6.84%	-16.41%	15.64%
EBIT Q/Q Growth	1.09%	-14.27%	15.59%
NOPAT Q/Q Growth	5.86%	-13.72%	3.75%
Net Income Q/Q Growth	37.83%	-22.56%	9.55%
EPS Q/Q Growth	16.67%	-5.41%	14.55%
Operating Cash Flow Q/Q Growth	-1.26%	-0.56%	9.94%
Free Cash Flow Firm Q/Q Growth	-2,212.36%	6.75%	86.33%
Invested Capital Q/Q Growth	-0.91%	-18.95%	-216.58%
Profitability Metrics	-	-	-
Gross Margin	76.44%	1.70%	0.00%
EBITDA Margin	-228.73%	-1,506.30%	0.00%
Operating Margin	-281.42%	-1,595.39%	0.00%
EBIT Margin	-275.70%	-1,585.32%	0.00%
Profit (Net Income) Margin	130.41%	-1,540.63%	0.00%
Tax Burden Percent	-43.88%	99.52%	98.60%
Interest Burden Percent	107.79%	97.65%	105.86%
Effective Tax Rate	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	-80.75%	-110.50%	0.00%
ROIC Less NNEP Spread (ROIC-NNEP)	-252.95%	-66.12%	0.00%
Return on Net Nonoperating Assets (RNNOA)	110.80%	32.13%	0.00%
Return on Equity (ROE)	30.04%	-78.37%	-136.30%
Cash Return on Invested Capital (CROIC)	-94.61%	-87.38%	0.00%
Operating Return on Assets (OROA)	-25.77%	-53.78%	0.00%
Return on Assets (ROA)	12.19%	-52.26%	0.00%
Return on Common Equity (ROCE)	30.04%	-78.37%	-115.54%
Return on Equity Simple (ROE_SIMPLE)	27.79%	-80.93%	-327.77%
Net Operating Profit after Tax (NOPAT)	-53	-70	-95
NOPAT Margin	-196.99%	-1,116.77%	0.00%
Net Nonoperating Expense Percent (NNEP)	172.20%	-44.37%	-39.45%
Return On Investment Capital (ROIC_SIMPLE)	-31.28%	-58.67%	-245.42%
Cost of Revenue to Revenue	23.56%	98.30%	0.00%
SG&A Expenses to Revenue	178.40%	649.24%	0.00%
R&D to Revenue	175.29%	780.95%	0.00%
Operating Expenses to Revenue	357.86%	1,597.09%	0.00%
Earnings before Interest and Taxes (EBIT)	-74	-99	-121
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-62	-94	-117
Valuation Ratios	-	-	-
Price to Book Value (P/BV)	2.51	2.81	8.52
Price to Tangible Book Value (P/TBV)	7.05	6.52	21.99
Price to Revenue (P/Rev)	11.76	53.58	0.00
Price to Earnings (P/E)	11.17	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%
Earnings Yield	8.95%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	3.71	4.86	0.00
Enterprise Value to Revenue (EV/Rev)	9.67	43.49	0.00
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00
Leverage & Solvency	-	-	-
Debt to Equity	0.34	0.00	0.00
Long-Term Debt to Equity	0.00	0.00	0.00
Financial Leverage	-0.44	-0.49	-0.87
Leverage Ratio	2.47	1.50	1.60
Compound Leverage Factor	2.66	1.46	1.69
Debt to Total Capital	25.50%	0.00%	0.00%
Short-Term Debt to Total Capital	25.50%	0.00%	0.00%
Long-Term Debt to Total Capital	0.00%	0.00%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	42.29%
Common Equity to Total Capital	74.50%	100.00%	57.71%
Debt to EBITDA	-0.70	0.00	0.00
Net Debt to EBITDA	0.91	0.00	0.00
Long-Term Debt to EBITDA	0.00	0.00	0.00
Debt to NOPAT	-0.82	0.00	0.00
Net Debt to NOPAT	1.06	0.00	0.00
Long-Term Debt to NOPAT	0.00	0.00	0.00
Altman Z-Score	-10.79	-13.81	-19.72
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	15.23%
Liquidity Ratios	-	-	-
Current Ratio	1.50	2.99	4.76
Quick Ratio	0.89	2.80	4.60
Cash Flow Metrics	-	-	-
Free Cash Flow to Firm (FCFF)	-62	-55	-7.70
Operating Cash Flow to CapEx	-1,502.19%	-4,654.38%	-799.78%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00
Efficiency Ratios	-	-	-
Asset Turnover	0.09	0.03	0.00
Accounts Receivable Turnover	3.41	0.81	0.00
Inventory Turnover	0.00	0.00	0.00
Fixed Asset Turnover	3.38	0.86	0.00
Accounts Payable Turnover	1.75	2.11	1.62
Days Sales Outstanding (DSO)	107.05	450.87	0.00
Days Inventory Outstanding (DIO)	0.00	0.00	0.00
Days Payable Outstanding (DPO)	208.84	172.81	224.84
Cash Conversion Cycle (CCC)	-101.79	278.06	0.00
Capital & Investment Metrics	-	-	-
Invested Capital	70	56	-31
Invested Capital Turnover	0.41	0.10	0.00
Increase / (Decrease) in Invested Capital	9.09	-15	-87
Enterprise Value (EV)	260	271	258
Market Capitalization	316	334	328
Book Value per Share	$0.61	$0.48	$0.13
Tangible Book Value per Share	$0.22	$0.21	$0.05
Total Capital	169	118	67
Total Debt	43	0.00	0.00
Total Long-Term Debt	0.00	0.00	0.00
Net Debt	-56	-63	-98
Capital Expenditures (CapEx)	4.33	1.44	8.52
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-17	-17	-17
Debt-free Net Working Capital (DFNWC)	83	46	81
Net Working Capital (NWC)	40	46	81
Net Nonoperating Expense (NNE)	-88	26	32
Net Nonoperating Obligations (NNO)	-56	-63	-98
Total Depreciation and Amortization (D&A)	13	4.92	3.64
Debt-free, Cash-free Net Working Capital to Revenue	-61.53%	-274.46%	0.00%
Debt-free Net Working Capital to Revenue	307.45%	735.26%	0.00%
Net Working Capital to Revenue	146.84%	735.26%	0.00%
Earnings Adjustments	-	-	-
Adjusted Basic Earnings per Share	$0.14	($0.39)	($0.47)
Adjusted Weighted Average Basic Shares Outstanding	200.36M	244.54M	267.73M
Adjusted Diluted Earnings per Share	$0.14	($0.39)	($0.47)
Adjusted Weighted Average Diluted Shares Outstanding	200.36M	244.54M	267.73M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	252.19M	248.92M	294.04M
Normalized Net Operating Profit after Tax (NOPAT)	-52	-62	-61
Normalized NOPAT Margin	-194.08%	-999.94%	0.00%
Pre Tax Income Margin	-297.17%	-1,547.98%	0.00%
Debt Service Ratios	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00
Payout Ratios	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%

This table displays calculated financial ratios and metrics derived from Precigen's official financial filings.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	401.71%	102.65%	-66.42%	-39.30%	-91.75%	-30.35%	-42.46%	-18.85%	-30.89%	-381.11%
EBITDA Growth	76.36%	-25.26%	-19.00%	2.48%	-457.33%	-67.64%	-7.51%	-198.74%	-21.23%	66.38%
EBIT Growth	69.64%	3.66%	-5.21%	12.63%	-214.11%	-57.22%	-5.52%	-188.47%	-17.38%	65.97%
NOPAT Growth	64.64%	17.79%	-5.98%	12.59%	-174.98%	-54.97%	-3.97%	-188.07%	-1.55%	15.58%
Net Income Growth	393.57%	38.48%	-18.09%	-15.22%	-122.65%	-114.62%	-4.42%	-189.34%	-21.13%	40.32%
EPS Growth	393.33%	15.38%	0.00%	11.11%	-118.18%	-18.18%	0.00%	-187.50%	-12.50%	61.54%
Operating Cash Flow Growth	-39.90%	-5.53%	2.10%	-123.56%	28.58%	-2.40%	23.37%	-46.54%	-33.66%	47.72%
Free Cash Flow Firm Growth	1,027.58%	-138.36%	615.64%	-148.70%	-123.14%	62.64%	-92.64%	113.78%	316.59%	834.85%
Invested Capital Growth	-45.55%	14.88%	-45.51%	32.54%	-3.08%	-20.72%	-28.02%	-66.55%	-61.04%	-156.03%
Revenue Q/Q Growth	474.44%	-89.46%	4.99%	-4.54%	-21.96%	-10.95%	-13.27%	34.65%	-33.54%	-462.22%
EBITDA Q/Q Growth	82.76%	-456.22%	-10.32%	7.80%	1.49%	-67.31%	29.25%	-156.20%	60.03%	53.60%
EBIT Q/Q Growth	72.74%	-227.46%	-7.26%	8.75%	1.99%	-63.90%	28.01%	-149.45%	60.12%	52.48%
NOPAT Q/Q Growth	68.49%	-186.28%	-7.71%	10.04%	0.87%	-61.33%	27.73%	-149.25%	65.05%	-34.12%
Net Income Q/Q Growth	595.49%	-117.63%	-47.60%	10.62%	2.58%	-66.99%	28.19%	-147.67%	59.22%	17.73%
EPS Q/Q Growth	588.89%	-125.00%	9.09%	20.00%	0.00%	-62.50%	23.08%	-130.00%	60.87%	44.44%
Operating Cash Flow Q/Q Growth	-237.63%	35.35%	-19.43%	14.25%	-7.86%	7.30%	10.63%	-64.00%	1.62%	63.74%
Free Cash Flow Firm Q/Q Growth	-18.27%	-145.16%	281.56%	-172.67%	61.17%	27.08%	135.75%	36.07%	510.52%	147.42%
Invested Capital Q/Q Growth	32.88%	-0.91%	3.44%	-2.69%	-2.83%	-18.95%	-6.08%	-54.78%	13.16%	-216.58%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	90.57%	28.70%	17.50%	3.96%	-11.46%	-10.59%	-0.94%	29.29%	-5.88%	0.00%
EBITDA Margin	-21.01%	-1,108.34%	-1,164.56%	-1,124.79%	-1,419.80%	-2,667.51%	-2,176.06%	-4,140.52%	-2,490.56%	0.00%
Operating Margin	-45.53%	-1,236.36%	-1,268.40%	-1,195.25%	-1,518.27%	-2,750.65%	-2,292.02%	-4,242.75%	-2,231.06%	0.00%
EBIT Margin	-39.33%	-1,221.44%	-1,247.87%	-1,192.76%	-1,497.90%	-2,757.00%	-2,288.54%	-4,239.75%	-2,544.28%	0.00%
Profit (Net Income) Margin	522.54%	-873.62%	-1,228.20%	-1,149.92%	-1,435.46%	-2,691.86%	-2,228.92%	-4,099.86%	-2,516.05%	0.00%
Tax Burden Percent	-1,135.68%	69.48%	99.76%	99.68%	99.97%	99.01%	99.88%	97.21%	100.05%	99.56%
Interest Burden Percent	117.00%	102.94%	98.66%	96.72%	95.86%	98.62%	97.51%	99.48%	98.84%	171.97%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	0.00%	-354.78%	-200.54%	-298.39%	-103.02%	-190.51%	-139.78%	-321.68%	-153.23%	0.00%
ROIC Less NNEP Spread (ROIC-NNEP)	0.00%	-354.49%	-176.37%	-287.08%	-96.20%	-174.68%	-131.27%	-293.52%	-136.34%	0.00%
Return on Net Nonoperating Assets (RNNOA)	0.00%	155.27%	35.63%	126.69%	49.96%	84.88%	72.97%	161.35%	72.28%	0.00%
Return on Equity (ROE)	18.60%	-199.50%	-164.91%	-171.70%	-53.05%	-105.63%	-66.81%	-160.33%	-80.95%	-136.30%
Cash Return on Invested Capital (CROIC)	2.93%	-94.61%	6.52%	-111.58%	-84.53%	-87.38%	-79.82%	-108.10%	-118.03%	0.00%
Operating Return on Assets (OROA)	0.00%	-114.16%	-100.53%	-99.72%	-45.01%	-93.52%	-66.14%	-154.25%	-86.86%	0.00%
Return on Assets (ROA)	0.00%	-81.65%	-98.95%	-96.14%	-43.13%	-91.31%	-64.42%	-149.16%	-85.90%	0.00%
Return on Common Equity (ROCE)	18.60%	-199.50%	-164.91%	-171.70%	-53.05%	-105.63%	-66.81%	-160.33%	-80.95%	-115.54%
Return on Equity Simple (ROE_SIMPLE)	17.86%	0.00%	17.17%	17.40%	-52.99%	0.00%	-99.89%	-313.60%	-252.03%	0.00%
Net Operating Profit after Tax (NOPAT)	-5.33	-15	-16	-15	-15	-24	-17	-43	-15	-20
NOPAT Margin	-31.87%	-865.45%	-887.88%	-836.67%	-1,062.79%	-1,925.46%	-1,604.41%	-2,969.92%	-1,561.74%	0.00%
Net Nonoperating Expense Percent (NNEP)	254.46%	-0.28%	-24.17%	-11.31%	-6.82%	-15.83%	-8.51%	-28.16%	-16.90%	0.29%
Return On Investment Capital (ROIC_SIMPLE)	-2.37%	-9.00%	-8.30%	-8.89%	-9.92%	-19.95%	-17.61%	-98.65%	-26.88%	-51.83%
Cost of Revenue to Revenue	9.43%	71.30%	82.50%	96.04%	111.46%	110.59%	100.94%	70.71%	105.88%	0.00%
SG&A Expenses to Revenue	60.62%	652.86%	628.80%	527.22%	666.86%	835.83%	953.15%	718.69%	1,032.11%	0.00%
R&D to Revenue	75.48%	612.20%	657.10%	671.99%	839.96%	1,058.14%	1,337.93%	1,094.35%	1,193.07%	0.00%
Operating Expenses to Revenue	136.10%	1,265.06%	1,285.90%	1,199.21%	1,506.82%	2,740.07%	2,291.08%	4,335.70%	2,225.18%	0.00%
Earnings before Interest and Taxes (EBIT)	-6.58	-22	-23	-21	-21	-34	-24	-61	-24	-12
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-3.51	-20	-22	-20	-20	-33	-23	-59	-24	-11
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	3.10	2.51	1.45	1.77	2.46	2.81	3.72	9.24	4.32	8.52
Price to Tangible Book Value (P/TBV)	6.96	7.05	2.59	3.39	5.16	6.52	11.37	30.30	9.32	21.99
Price to Revenue (P/Rev)	0.00	11.76	11.50	13.29	53.67	53.58	66.36	78.11	51.15	0.00
Price to Earnings (P/E)	19.37	11.17	10.76	13.26	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	5.16%	8.95%	9.29%	7.54%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	5.22	3.71	2.15	2.81	4.13	4.86	6.05	16.05	7.88	0.00
Enterprise Value to Revenue (EV/Rev)	0.00	9.67	6.70	8.97	41.98	43.49	58.13	74.28	45.03	0.00
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	125.71	0.00	23.22	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.58	0.34	0.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Financial Leverage	-0.27	-0.44	-0.20	-0.44	-0.52	-0.49	-0.56	-0.55	-0.53	-0.87
Leverage Ratio	2.32	2.47	2.24	2.38	1.55	1.50	1.34	1.34	1.35	1.60
Compound Leverage Factor	2.72	2.54	2.21	2.31	1.49	1.48	1.31	1.33	1.33	2.75
Debt to Total Capital	36.54%	25.50%	6.98%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Short-Term Debt to Total Capital	36.54%	25.50%	6.98%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	42.29%
Common Equity to Total Capital	63.46%	74.50%	93.02%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	57.71%
Debt to EBITDA	-1.42	-0.70	-0.21	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt to EBITDA	1.24	0.91	1.72	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Debt to NOPAT	-1.46	-0.82	-0.26	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt to NOPAT	1.27	1.06	2.07	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Altman Z-Score	-7.68	-9.98	-7.94	-8.43	-9.06	-12.39	-15.29	-33.85	-30.33	-17.24
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	15.23%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.55	1.50	2.95	3.43	2.83	2.99	1.72	1.03	1.63	4.76
Quick Ratio	0.70	0.89	2.56	3.34	2.67	2.80	1.60	0.89	1.38	4.60
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	54	-24	44	-32	-12	-9.10	3.25	4.43	27	67
Operating Cash Flow to CapEx	-1,679.34%	-29,049.06%	-11,940.26%	-39,420.00%	-7,206.78%	-1,564.09%	-324.06%	-994.71%	-2,755.52%	-801.85%
Free Cash Flow to Firm to Interest Expense	26.48	0.00	136.45	0.00	0.00	0.00	1,626.50	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	-11.70	0.00	-56.75	0.00	0.00	0.00	-7,045.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	-12.39	0.00	-57.23	0.00	0.00	0.00	-9,219.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.00	0.09	0.08	0.08	0.03	0.03	0.03	0.04	0.03	0.00
Accounts Receivable Turnover	0.00	3.41	1.15	2.72	0.82	0.81	0.65	0.66	0.63	0.00
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	0.00	3.38	1.15	3.09	0.92	0.86	0.56	0.51	0.45	0.00
Accounts Payable Turnover	0.00	1.75	1.50	2.31	1.84	2.11	1.33	1.36	1.34	1.62
Days Sales Outstanding (DSO)	0.00	107.05	317.07	134.40	447.04	450.87	559.81	551.22	578.46	0.00
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	0.00	208.84	243.94	157.74	198.69	172.81	274.54	269.36	273.22	224.84
Cash Conversion Cycle (CCC)	0.00	-101.79	73.12	-23.34	248.35	278.06	285.28	281.86	305.25	0.00
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	71	70	73	71	69	56	52	24	27	-31
Invested Capital Turnover	0.00	0.41	0.23	0.36	0.10	0.10	0.09	0.11	0.10	0.00
Increase / (Decrease) in Invested Capital	-59	9.09	-61	17	-2.18	-15	-20	-47	-42	-87
Enterprise Value (EV)	370	260	156	198	284	271	316	379	211	258
Market Capitalization	441	316	267	294	363	334	361	399	239	328
Book Value per Share	$0.68	$0.61	$0.73	$0.65	$0.58	$0.48	$0.39	$0.17	$0.22	$0.13
Tangible Book Value per Share	$0.30	$0.22	$0.41	$0.34	$0.28	$0.21	$0.13	$0.05	$0.10	$0.05
Total Capital	225	169	198	166	148	118	97	43	55	67
Total Debt	82	43	14	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Long-Term Debt	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt	-72	-56	-112	-96	-79	-63	-45	-20	-29	-98
Capital Expenditures (CapEx)	1.42	0.05	0.15	0.04	0.24	1.01	4.35	2.32	0.83	1.03
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-14	-17	-13	-14	-14	-17	-24	-19	-15	-17
Debt-free Net Working Capital (DFNWC)	140	83	105	75	60	46	21	0.69	13	81
Net Working Capital (NWC)	58	40	91	75	60	46	21	0.69	13	81
Net Nonoperating Expense (NNE)	-93	0.14	6.30	5.54	5.14	9.41	6.65	16	9.09	-0.23
Net Nonoperating Obligations (NNO)	-72	-56	-112	-96	-79	-63	-45	-20	-29	-98
Total Depreciation and Amortization (D&A)	3.06	1.99	1.54	1.20	1.08	1.10	1.20	1.42	0.51	0.51
Debt-free, Cash-free Net Working Capital to Revenue	0.00%	-61.53%	-56.19%	-61.42%	-201.80%	-274.46%	-441.00%	-369.06%	-327.65%	0.00%
Debt-free Net Working Capital to Revenue	0.00%	307.45%	450.94%	338.68%	889.25%	735.26%	381.91%	13.55%	284.12%	0.00%
Net Working Capital to Revenue	0.00%	146.84%	391.49%	338.68%	889.25%	735.26%	381.91%	13.55%	284.12%	0.00%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.44	($0.11)	($0.10)	($0.08)	($0.08)	($0.13)	($0.10)	($0.23)	($0.09)	($0.05)
Adjusted Weighted Average Basic Shares Outstanding	200.67M	200.36M	229.77M	248.00M	248.52M	244.54M	249.22M	252.37M	275.88M	267.73M
Adjusted Diluted Earnings per Share	$0.44	($0.11)	($0.10)	($0.08)	($0.08)	($0.13)	($0.10)	($0.23)	($0.09)	($0.05)
Adjusted Weighted Average Diluted Shares Outstanding	200.67M	200.36M	229.77M	248.00M	248.52M	244.54M	249.22M	252.37M	275.88M	267.73M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	208.15M	252.19M	255.48M	255.48M	248.92M	248.92M	252.42M	252.76M	292.87M	294.04M
Normalized Net Operating Profit after Tax (NOPAT)	-5.33	-15	-16	-15	-15	-24	-17	-17	-15	-20
Normalized NOPAT Margin	-31.87%	-865.45%	-887.88%	-836.67%	-1,062.79%	-1,925.46%	-1,604.41%	-1,204.06%	-1,561.74%	0.00%
Pre Tax Income Margin	-46.01%	-1,257.40%	-1,231.17%	-1,153.59%	-1,435.90%	-2,718.89%	-2,231.64%	-4,217.64%	-2,514.80%	0.00%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	-3.23	0.00	-71.29	0.00	0.00	0.00	-12,186.50	0.00	0.00	0.00
NOPAT to Interest Expense	-2.62	0.00	-50.72	0.00	0.00	0.00	-8,543.50	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	-3.93	0.00	-71.77	0.00	0.00	0.00	-14,360.50	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	-3.31	0.00	-51.20	0.00	0.00	0.00	-10,717.50	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Frequently Asked Questions About Precigen's Financials

When does Precigen's fiscal year end?

According to the most recent income statement we have on file, Precigen's financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has Precigen's net income changed over the last 2 years?

Precigen's net income appears to be on an upward trend, with a most recent value of -$126.24 million in 2024, falling from $35.09 million in 2022. The previous period was -$95.90 million in 2023.

What is Precigen's operating income?

Precigen's total operating income in 2024 was -$135.03 million, based on the following breakdown:

Total Gross Profit: -$4.27 million
Total Operating Expenses: $142.10 million

How has Precigen revenue changed over the last 2 years?

Over the last 2 years, Precigen's total revenue changed from $26.91 million in 2022 to $0.00 in 2024, a change of -100.0%.

How much debt does Precigen have?

Precigen's total liabilities were at $78.54 million at the end of 2024, a 141.3% increase from 2023, and a 12.5% decrease since 2022.

How much cash does Precigen have?

In the past 2 years, Precigen's cash and equivalents has ranged from $4.86 million in 2022 to $29.52 million in 2024, and is currently $29.52 million as of their latest financial filing in 2024.

How has Precigen's book value per share changed over the last 2 years?

Over the last 2 years, Precigen's book value per share changed from 0.61 in 2022 to 0.13 in 2024, a change of -78.3%.

Related Companies

This page (NASDAQ:PGEN) was last updated on 4/20/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Precigen (PGEN) Financials

Frequently Asked Questions About Precigen's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Precigen (PGEN) Financials

Annual Income Statements for Precigen

Quarterly Income Statements for Precigen

Annual Cash Flow Statements for Precigen

Quarterly Cash Flow Statements for Precigen

Annual Balance Sheets for Precigen

Quarterly Balance Sheets for Precigen

Annual Metrics and Ratios for Precigen

Quarterly Metrics and Ratios for Precigen

Frequently Asked Questions About Precigen's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools